The procedure described herein is a direct amide coupling of nonactivated carboxylic acids and amines catalyzed by zirconium (IV) chloride. The amide functionality is of major importance in many scientific areas, for example in material science, chemistry, and biology. The amide functionality is one of the most synthesized within the pharmaceutical industry, and it has been estimated that 25% of the pharmaceutical compounds available on the market contain at least one amide bond. The importance of the amide bond is further emphasized by the fact that 2/3 of 128 drug candidates covered in a survey from Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer in 2006 made use of amide couplings. This method described is a mild and selective metal‐catalyzed protocol, giving rise to high yields of the desired products at moderate reaction temperatures, and without racemizing chiral amino acids. The method stems from our recent work where we have shown that early transition metal complexes such as ZrCl
4
or Ti(OPr
i
)
4
are excellent catalysts for a range of substrates, including the formation of both secondary and tertiary amides, as well as chiral amides.